Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ian Neeland MD, FAHA, FACC

Ian J. Neeland MD, FAHA, FACC

Director, UH Center for Cardiovascular Prevention and Translational Science Unit; Co-Director, Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA), Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center; Associate Professor of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio

Ian J. Neeland, MD, is Director of the University Hospitals Center for Cardiovascular Prevention, Director of the Translational Science Unit, and Co-director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA program) for University Hospitals Harrington Heart & Vascular Institute and Associate Professor of Medicine at Case Western Reserve University School of Medicine in Cleveland, Ohio. He is a general and preventive cardiologist with special expertise in obesity, diabetes and prevention of cardiovascular disease.

Dr. Neeland earned his medical degree at Mount Sinai School of Medicine in New York City. He completed a residency in internal medicine and was chief medical resident at Emory University School of Medicine in Atlanta, and then completed a combined clinical and research fellowship in cardiovascular medicine at UT Southwestern Medical Center in Dallas. He also holds a certificate in translational medicine from Emory's Laney Graduate School. Certified by the American Board of Internal Medicine in both internal medicine and cardiovascular diseases, he also holds a subspecialty certification in adult echocardiography from the National Board of Echocardiography.

Dr. Neeland is an active clinical and translational investigator with funding from the National Institutes of Health and industry. He has published over 110 scholarly articles and delivered a number of national, international and regionally invited lectures. He is a reviewer for many respected journals, including Circulation, for which he currently serves as an associate editor and section editor for Bridging Disciplines.

Dr. Neeland is a Fellow of the American Heart Association and American College of Cardiology and serves on several national committees with the American Heart Association. Dr. Neeland is a member of professional organizations that include the AHA Council on Epidemiology and Prevention and the Council on Lifestyle and Cardiometabolic Health; American College of Cardiology; and American Society for Preventive Cardiology.

Disclosures

Dr. Neeland is a consultant/speaker for:
  • Boheringer Ingelheim/Lilly Alliance
  • Bayer Pharmaceuticals
  • Nestle Health Science